Previous Article | Next Article ![]()
Molecular and Cellular Biology, February 2006, p. 1386-1397, Vol. 26, No. 4
0270-7306/06/$08.00+0 doi:10.1128/MCB.26.4.1386-1397.2006
Copyright © 2006, American Society for Microbiology. All Rights Reserved.
Division of Basic Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington 98109-1024,1 Institute for Systems Biology, Seattle, Washington 98103-8904,2 Children's Cancer Research Institute, The University of Texas Health Science Center, San Antonio, Texas 78229-3900,3 Department of Medicine and Cancer Center, University of California at San Diego, San Diego, California 92093-0673,4 Institute for Molecular Systems Biology, ETH-Zurich, and Faculty of Natural Sciences, University of Zurich, Zurich, Switzerland5
Received 5 July 2005/ Returned for modification 25 July 2005/ Accepted 25 November 2005
|
|
|---|
|
|
|---|
mSin3A and mSin3B function as corepressors utilized by a growing number of transcriptional repressors such as MeCP2 (44), Ikaros (27), Pf1 (63), MNFß (60), and Elk-1 (61). These mSin3-dependent transcriptional repressors function in diverse cellular processes, including proliferation, differentiation, apoptosis, and tumorigenesis. Recent genetic studies in mice have shown that mSin3A is an essential gene that is involved in cell fate determination (8, 9). Hence, understanding the function of the mSin3 complex will provide insight not only into the mechanism of mSin3/HDAC-dependent transcriptional repression but also into diverse aspects of cell behavior. In vivo, mSin3A is found associated with a large multiprotein complex containing HDAC1, HDAC2, RbAP46/48, SAP180, SAP130, SAP45/mSDS3, SAP30, SAP18, and other as yet uncharacterized proteins (1, 15, 18, 32, 64, 65). Some of these mSin3-binding proteins such as mSDS3 and SAP30 function as a "bridge" between the mSin3 complex and other protein complexes.
The broad elution pattern of the mSin3 complex from
size exclusion columns
(30,
52,
58) suggests that there
are multiple mSin3 complexes containing different components in
substoichiometric quantities. To fully understand the biological roles
and regulation of mSin3 complexes, it is important to identify proteins
that interact with mSin3. With this in mind, we have undertaken the
identification of novel mSin3-binding proteins using
gt11
expression protein-protein interaction screening. Here we report the
cloning and characterization of a novel mSin3A-binding protein,
SAP25.
|
|
|---|
Cell culture. 293, 293T, and BALB/c 3T3 cells were cultured in Dulbecco's modified Eagle's medium supplemented with 10% calf serum. HeLa cells, IMR-90 cells, and Rat1 cells were cultured in Dulbecco's modified Eagle's medium supplemented with 10% fetal calf serum. Calcium phosphate coprecipitation was used for transfection.
Northern blotting. Total cellular RNA was prepared as described previously (7). Twenty micrograms of total RNA was analyzed by Northern blotting. An adult mouse multiple-tissue Northern blot was purchased from Clontech.
Immunoprecipitation and immunoblotting. Immunoprecipitation and immunoblotting were performed as described previously (50). For metabolic labeling, the cells were incubated in methionine-free media for 30 min and labeled with 0.25 mCi/ml of [35S]methionine for 4 h. Anti-SAP25 rabbit polyclonal antibody was raised against His-tagged, full-length SAP25 produced by baculoviral expression. A ca. 25-kDa protein band detected by immunoprecipitation of [35S]Met-labeled cell lysates or by immunoblotting using this antibody can be blocked by preincubating the antibody with the immunogen, verifying the specificity of the antibody. Anti-HDAC2 was obtained from Ed Seto. Anti-mSin3A rabbit polyclonal antibody was raised against GST-PAH2. Anti-mitogen-activated protein kinase (anti-MAPK) antibody was obtained from Yoshiro Maru. Anti-Myc antibody was prepared from 9E10 hybridoma ascites fluid. Anti-FLAG M2 monoclonal antibody was purchased from Sigma.
ICAT proteomic analysis of SAP25 complex. HeLa cells (50 10-cm plates each) were transfected with FLAG-SAP25 alone or FLAG-SAP25 plus promyelocytic leukemia protein (PML). Forty-eight hours after transfection, the cell lysates were immunoprecipitated with anti-FLAG antibody under nondenaturing conditions and the precipitated proteins were eluted with FLAG peptide. The two protein complexes (ca. 70 µg each) were labeled with the cleavable isotope-coded affinity tag (ICAT) reagents (isotopically light ICAT for the FLAG-SAP25 sample and isotopically heavy ICAT for the FLAG-SAP25-plus-PML sample). The labeled protein mixtures were combined and proteolyzed to peptides with trypsin. The peptides were fractionated by cation-exchange chromatography (using an SCX cartridge from Applied Biosystems), followed by avidin affinity chromatography (using a monomeric avidin cartridge from Applied Biosystems). The isolated ICAT-labeled peptides were analyzed by microcapillary liquid chromatography-tandem mass spectrometry as described previously (16, 17, 49, 51). The amino acid sequences of the peptides were determined by correlating the collision-induced dissociation spectra with the protein sequence database using the SEQUEST search algorithm (13). The accuracy of peptide/protein identification was statistically validated by using the Peptide Prophet (25) and Protein Prophet (45) software tools. The relative abundance (FLAG-SAP25 alone versus FLAG-SAP25 plus PML) of an identified ICAT-labeled peptide pair was determined from the ratio of the peptide peaks using the ASAPRatio software tool (39).
Immunofluorescence. Immunofluorescence was performed as described previously (49). Anti-human PML 5E10 monoclonal antibody was obtained from Roel van Driel.
GST pulldown assay. In vitro-translated, [35S]Met-labeled protein was incubated with 5 µg of purified GST fusion protein in 1x phosphate-buffered saline containing 0.4% NP-40 for 1 h at 4°C and washed three times, and bound proteins were analyzed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE).
Luciferase assay. The 4x GAL14D luciferase was described previously (3). The luciferase assay was performed as described in reference 50.
Microinjection reporter assay. The microinjection experiments (32) were performed in NIH 3T3 cells that had been serum deprived overnight prior to injection. For the antibody experiments, the DNA constructs were added at 100 µg/ml to either preimmune rabbit immunoglobulin G (IgG) or purified IgG raised against SAP25. Injected cells were detected by staining after incubation with tetramethyl rhodamine isothiocyanate (TRITC)-labeled donkey anti-rabbit IgG (Jackson Laboratories). Small interfering RNAs (siRNAs) were coinjected at a concentration of 50 nM with rhodamine-conjugated dextran (Molecular Probes). The target sequence of SAP25 siRNA was 5'-CTTCCTGGCCGATGTATGA-3'. Cells were fixed and stained overnight with X-Gal (5-bromo-4-chloro-3-indolyl-ß-D-galactopyranoside) 24 h after injection for the antibody experiments and 48 h after injection for the siRNA experiments. LacZ expression was quantitated on an epifluorescence microscope. Each fluorescent-injected cell was individually scored as positive or negative for reporter expression, with any degree of staining for LacZ denoted as positive. Two hundred to 300 cells were injected for each experimental parameter, and each experiment was repeated at least three times. Results are expressed as percent blue cells, which represents the mean of all experiments + standard error.
|
|
|---|
gt11 expression screens
(5) with either
baculovirus-produced full-length mSin3A or the mixture of bacterial
GST-PAH1, -2, -3, and -4 as probes using a mouse 10-day-embryo cDNA
library (Novagen). In each case, 2.4 x 106 plaques
were screened and one clone, containing an open reading frame (ORF)
encoding 186 amino acids, was isolated (Fig.
1A). This ORF is preceded by an in-frame stop codon, and the sequence
surrounding the putative initiation codon conforms to the start codon
consensus sequence (28).
The SAP25 cDNA sequence is nearly identical to the 3' portion
of RIKEN cDNA 2810008P14 (IMAGE: 5353990). The deduced SAP25 amino acid
sequence contains two LXXLL motifs. Such motifs have been previously
implicated in the binding of steroid receptor coactivators with nuclear
hormone receptors or cyclin D1
(20,
66). There is a human
SAP25 homologue (FLJ00248 protein), and the C-terminal LXXLL motif and
surrounding sequences are well conserved, although the N-terminal LXXLL
motif is changed to SXXLL in human SAP25. Except for the LXXLL motifs,
the SAP25 amino acid sequence does not contain any recognizable
sequence motifs and does not display any significant homology to other
proteins in the database.
![]() View larger version (45K): [in a new window] |
FIG. 1. Cloning
of SAP25. (A) Deduced amino acid sequence of SAP25. The SAP25
open reading frame encodes a 186-amino-acid protein. The LXXLL motifs
are underlined. (B) Tissue distribution of SAP25 mRNA
expression. An adult mouse multiple-tissue Northern blot (Clontech) was
probed with 32P-labeled SAP25 cDNA fragment. (C)
SAP25 mRNA expression upon different stimuli. Mouse BALB/c3T3
fibroblasts were deprived of serum overnight (lane 2) and treated with
UV light (3.5 h after 254-nm UV irradiation at 1 mJ/cm2)
(lane 3), HDAC inhibitor TSA (1 ng/ml overnight) (lane 4), or
proteasome-inhibitor LLnL (50 µM overnight) (lane 5), and SAP25
mRNA expression was examined by Northern blotting. (D)
Induction of SAP25 protein expression upon serum starvation. Mouse
BALB/c3T3 fibroblasts cultured with (lanes 4 and 5) or without (lanes 2
and 3) serum were labeled with [35S]Met, and tricarboxylic
acid-insoluble count-normalized lysates were
immunoprecipitated with anti-SAP25 antibody (lanes 3 and 5) or with
preimmune serum (lanes 2 and 4). The arrow indicates the position of
endogenous SAP25 protein, which migrates slightly slower than the in
vitro-translated (IVT) SAP25 (lane 1,
arrowhead).
|
SAP25 RNA and protein expression was found to be induced upon serum starvation of BALB/c3T3 fibroblasts (Fig. 1C and D), which may suggest a role of SAP25 in cell cycle arrest. UV, a histone deacetylase inhibitor, trichostatin A (TSA), and a proteasome inhibitor, LLnL, did not have any effect on SAP25 mRNA expression (Fig. 1C).
In vitro interaction of SAP25 and mSin3A. To map the SAP25-binding domain on mSin3A, we examined the binding of a series of C-terminal deletion mutants of mSin3A to GST-SAP25. As shown in Fig. 2A, all the C-terminal deletion mutants up to N205 bind to GST-SAP25. Note that although the full-length and N680 deletion mutant mSin3A displayed some binding to GST alone, they displayed clearly more binding to GST-SAP25. N205 contains the N-terminal sequence, including the PAH1 domain. The requirement of the PAH1 domain for SAP25 binding was examined by deleting the PAH1 domain from mSin3A. As shown in Fig. 2B, an mSin3A N-terminal deletion mutant that lacks the PAH1 domain does not bind, whereas full-length mSin3A and the N-terminal fragment containing the PAH1 domain bind GST-SAP25. The binding of the PAH1 domain to SAP25 was further confirmed by the interaction of full-length SAP25 and GST-PAH1 (Fig. 2C). The two bands detected for in vitro-translated SAP25 in Fig. 2C are likely due to internal initiation of translation.
![]() View larger version (18K): [in a new window] |
FIG. 2. Interaction
of SAP25 and the PAH1 domain of mSin3A. (A) Interaction of
C-terminal deletion mutants of mSin3A with GST-SAP25. The indicated
mSin3A C-terminal deletion mutants were in vitro translated,
[35S]Met labeled, and incubated with GST-SAP25 or GST
attached to glutathione agarose beads. The bound proteins were analyzed
by SDS-PAGE. Input lanes contain 20% of the input to the binding
reaction. (B) Requirement for the PAH1 domain of mSin3A for
SAP25 binding. Full-length mSin3A (full), an mSin3A N-terminal
205-amino-acid fragment that contains the PAH1 domain (PAH1), or the
mSin3A N-terminal deletion mutant that lacks the PAH1 domain
( PAH1, deletion of the N-terminal 206 amino acids) was
analyzed for GST-SAP25 binding as in panel A. Input lanes contain 20%
of the input to the binding reaction. (C) Interaction of
SAP25 with the PAH1 domain. Full-length SAP25 protein was analyzed for
binding to GST, GST-PAH1, or GST-PAH2 as in panel A. Input lanes
contain one-seventh of the input to the binding
reaction.
|
-helical structure (I. Radhakrishnan,
personal communication).
![]() View larger version (26K): [in a new window] |
FIG. 3. Role
of the LXXLL motif of SAP25 in binding to mSin3A PAH1. (A)
Interaction of the deletion mutants of SAP25 with GST-PAH1. The
indicated SAP25 deletion mutants were analyzed for binding to GST-PAH1
or GST as in Fig. 2A. The
input lanes contain 20% of the input to the binding reaction. The
Sin3 interaction domain (SID) of SAP25 is
located in the C-terminal one-third of the protein (positions 125 to
186). (B) Requirement of the C-terminal LXXLL motif of SAP25
for binding to the PAH1 domain of mSin3A. Wild-type SAP25 or the SAP25
mutants that have mutations in the C-terminal LXXLL motif
(LAGLL AAGLL or LAGLL LAGAA) were analyzed for binding
to GST-PAH1. Input lanes contain 20% of the input to the binding
reaction. (C) Specific interaction of SAP25 LXXLL motif with
mSin3A PAH1. Cyclin D1, estrogen receptor (ER ),
estrogen receptor ß (ERß), or mSin3A PAH1 fragment was
analyzed for binding to GST-SAP25 or GST alone. The interaction of
ER and ERß was examined in both the presence and
absence of the ligand
(E2).
|
, or estrogen receptor ß, indicating
that the LXXLL motif of SAP25 is relatively specific for binding to the
PAH1 domain of mSin3A. Such interaction specificity for LXXLL motifs
has been previously described
(19,
66), although the
determinants of specificity have not been clearly
defined. In vivo interaction of SAP25 and mSin3A complex. To determine if SAP25 binds to other cellular proteins in vivo, we transfected FLAG-tagged SAP25 into 293T cells, metabolically labeled the cells with [35S]methionine, and performed immunoprecipitation under nondenaturing conditions. As shown in Fig. 4A, FLAG-SAP25 was expressed as a ca. 26-kDa protein and coimmunoprecipitated with several cellular proteins. A doublet of ca. 150 kDa and a band of ca. 60 kDa are approximately the expected sizes of endogenous mSin3A and HDAC, respectively (4, 18, 64). This was confirmed by analyzing the FLAG-SAP25 immunoprecipitate by immunoblotting. As shown in Fig. 4B, endogenous mSin3A and HDAC2 coimmunoprecipitate with FLAG-SAP25 from 293 cells. Furthermore, association of endogenous mSin3A and endogenous SAP25 in 293 cells was confirmed by anti-mSin3A immunoprecipitation followed by anti-SAP25 immunoblotting (Fig. 4C).
![]() View larger version (36K): [in a new window] |
FIG. 4. Interaction
of SAP25 with mSin3A complex in vivo. (A) Interaction of
FLAG-SAP25 with cellular proteins. FLAG-SAP25 or FLAG empty vector was
transfected into 293T cells. Two days later, the cells were labeled
with [35S]Met, lysed in TNE buffer (lanes 1 and 2) or
high-salt buffer (lanes 3 and 4), immunoprecipitated with anti-FLAG
antibody, and analyzed by 7.5% (left) or 15% (right) SDS-PAGE. Lanes 1
and 3 contain FLAG-SAP25 samples, and lanes 2 and 4 contain FLAG empty
vector samples. FLAG-SAP25 was expressed as a ca. 26-kDa protein. The
proteins coimmunoprecipitated with FLAG-SAP25 are marked with arrows.
(B) Interaction of FLAG-SAP25 with mSin3A and HDAC2 in 293
cells. FLAG-SAP25 (F25) or FLAG empty vector (FV) was transfected into
293 cells. Two days later, the cells were lysed in TNE buffer and
immunoprecipitated (IP) with anti-FLAG ( -FLAG) antibody.
The cell lysates and immunoprecipitates were analyzed by
anti-mSin3A, anti-HDAC2, or anti-FLAG immunoblotting. (C)
Interaction of endogenous mSin3A and SAP25 in 293 cells. 293 cell
lysates were immunoprecipitated with anti-mSin3A antibody or preimmune
serum, and the immunoprecipitates were analyzed by anti-mSin3A (top)
and anti-SAP25 (bottom)
immunoblotting.
|
![]() View larger version (16K): [in a new window] |
FIG. 5. Transcriptional
repression by GAL4-SAP25. HeLa cells were cotransfected with 4x
GAL14D-luciferase reporter and GAL4 vector, GAL4-SAP25,
GAL4-SAP25(125-186), or GAL4-SAP25(1-124). The luciferase activities
were determined 48 h after transfection. Transfection
efficiency was normalized using a ß-galactosidase assay. The
data represent the average of three independent
experiments.
|
Involvement of SAP25 in mSin3A-mediated repression. The functional significance of SAP25 association with mSin3A complex was examined by live cell microinjection reporter assays (Fig. 6) (32). GAL4-mSin3A represses transcription of 3XUAStk/lacZ reporter, as previously observed (32). Microinjection of anti-SAP25 antibody completely abolishes repression by GAL4-mSin3A, indicating that SAP25 is required for mSin3A-mediated repression. In contrast, microinjection of anti-SAP25 antibody does not affect repression by GAL4-N-CoR, which is consistent with the lack of interaction between SAP25 and N-CoR both in vitro and in vivo (Y. Shiio and R. N. Eisenman, unpublished data). Microinjection of anti-SAP25 antibody does not affect the basal and liganded activities of retinoic acid receptor, estrogen receptor, thyroid hormone receptor, and progesterone receptor (data not shown). This is consistent with the specific recruitment of N-CoR/SMRT, but not mSin3A, by thyroid hormone receptor (38). GAL4-SAP25 represses transcription of 3XUAStk/lacZ reporter, and this repression is abolished by microinjection of mSin3A antibody (Fig. 6), which is consistent with the requirement for the mSin3A-binding domain in GAL4-SAP25-mediated repression (Fig. 5). To further confirm the role of SAP25 in mSin3A-mediated repression, we microinjected SAP25 siRNA or control siRNA and analyzed their effects on GAL4-mSin3A repression. As shown in Fig. 6B, SAP25 siRNA (see Materials and Methods), but not control siRNA, partly relieved GAL4-mSin3A repression. Taken together our results indicate that SAP25 is involved in mSin3A-mediated, but not N-CoR-mediated, repression.
![]() View larger version (14K): [in a new window] |
FIG. 6. SAP25
mediates repression by mSin3A (A) Repression of the
3XUAStk/lacZ reporter by the indicated GAL4-mSin3A, GAL4-N-CoR, or
GAL4-SAP25 fusion proteins was assayed in microinjected NIH 3T3 cells.
Anti-SAP25 or anti-mSin3A was coinjected as indicated. As a negative
control, we used preimmune rabbit IgG, which did not affect the
fraction of X-Gal-positive cells. Fold repression was determined by
comparing the percentage of X-Gal-positive, injected cells in the
presence of GAL4-mSin3A, GAL4-N-CoR, or GAL4-SAP25 relative to GAL4
alone. Two hundred to 300 cells were injected for each experimental
parameter. The results are the average of two experiments performed in
triplicate. (B) Repression of the 3XUAStk/lacZ reporter by
GAL4-mSin3A was assayed in microinjected NIH 3T3 cells. SAP25 siRNA or
control scrambled siRNA was coinjected as
indicated.
|
![]() View larger version (32K): [in a new window] |
FIG. 7. Nuclear
export of SAP25. (A) Alignment of the sequences of the LXXLL
motifs in SAP25 and known leucine-rich nuclear export signals.
(B) Subcellular location of FLAG-SAP25 in the presence or
absence of leptomycin B. HeLa cells were transfected with FLAG-SAP25,
and 24 h later the cells were either left untreated or
treated with 5 ng/ml of leptomycin B for 24 h. The location
of FLAG-SAP25 was determined by anti-FLAG indirect immunofluorescence.
Nuclei were stained with Hoechst 33258. (C) Mapping of the
nuclear export signals of SAP25. The subcellular location of the
indicated deletion or substitution mutants of SAP25 was determined as
in panel B. Predominant locations in the cytoplasm (C), the nucleus
(N), or both (C+N) are indicated. More than 200 cells were
examined for each location analysis. (D) Cytoplasmic
sequestration of mSin3A by SAP25. HeLa cells were transfected with
myc-tagged mSin3A, SAP25, or both, and their subcellular location
was examined by anti-myc (9E10) and anti-SAP25 immunofluorescence. Nuclei were
stained with Hoechst 33258. Where indicated, the transfected cells were
treated with 5 ng/ml of leptomycin B. (E) Biochemical fractionation of
SAP25-transfected cells. HeLa cells transfected with FLAG-SAP25 were
fractionated into cytoplasmic and nuclear fractions by the method of
Dignam et al. (12), and
FLAG-SAP25 was detected by anti-FLAG immunoblotting. Anti-MAPK and
anti-c-Myc immunoblots serve as fractionation controls.
|
The predominantly cytoplasmic localization of FLAG-SAP25 as determined by immunofluorescence prompted us to examine the subcellular location of SAP25 by biochemical fractionation. As shown in Fig. 7E, although the majority of FLAG-SAP25 was located in the cytoplasm, a significant fraction was present in the nucleus and cofractionates with Myc, which is exclusively nuclear and serves as a positive control. The nuclear fraction of SAP25, which can interact with nuclear mSin3A, is likely to be regulated by CRM1-dependent nuclear export. SAP25 may also have an mSin3A-independent role in the cytoplasm.
Localization of SAP25 to PML nuclear bodies. Immunofluorescent staining of endogenous SAP25 in HeLa cells revealed that it is mainly cytoplasmic, but a fraction of SAP25 is located in the nucleus and is concentrated in nuclear dot-like structures which coincide with the PML nuclear bodies (Fig. 8A, top row). Leptomycin B treatment caused accumulation of SAP25 in the PML nuclear bodies (Fig. 8A, second row). Although SAP25 mRNA and protein are induced by serum starvation (Fig. 1C and D), serum starvation does not affect the subcellular location of SAP25 (data not shown). Transfected SAP25 was predominantly cytoplasmic, but coexpression of PML caused accumulation of SAP25 in the PML nuclear bodies (which are enlarged by overexpression of PML) and the nucleoplasm (Fig. 8A, third and fourth rows). The PML nuclear bodies increase in size and number upon Ras-induced senescence of primary fibroblasts and play a pivotal role in this process (14, 46). Thus, we examined the subcellular location of SAP25 upon oncogenic H-Ras-induced senescence. As shown in Fig. 8B, SAP25 accumulated in the PML nuclear bodies upon Ras-induced senescence of human IMR-90 fibroblasts. Accumulation of SAP25 in the nucleus was also observed upon Ras-induced senescence of rat REF52 fibroblasts (data not shown). SAP25 may play a role in the regulation of cellular senescence through recruitment of mSin3-HDAC complex to the PML nuclear bodies.
![]() View larger version (19K): [in a new window] |
FIG. 8. Localization
of SAP25 in PML nuclear bodies. (A) Localization of SAP25 in
PML nuclear bodies in HeLa cells. Untreated HeLa cells or HeLa cells
treated with 5 ng/ml of leptomycin B for 24 h were stained
for SAP25 or PML (top and second rows). In untreated HeLa cells, SAP25
is mainly cytoplasmic, but a fraction of SAP25 is located in the
nucleus and is concentrated in the nuclear dot-like structures that
coincide with PML nuclear bodies (indicated by arrows, top row). Upon
leptomycin B treatment, SAP25 accumulated in the nucleus and in PML
nuclear bodies (indicated by arrows, second row). HeLa cells were
transfected with SAP25 or SAP25 and PML. After 48 h, the
cells were stained for SAP25 and PML (third and fourth rows).
Transfected SAP25 was predominantly cytoplasmic (third row), but
coexpression of PML caused accumulation of SAP25 in PML nuclear bodies
and the nucleoplasm (fourth row). (B) Accumulation of SAP25
in PML nuclear bodies upon Ras-induced senescence of human IMR-90
fibroblasts. IMR-90 fibroblasts were infected with retroviruses
expressing activated Ras or empty vector retroviruses. Infected cells
were selected with puromycin for 2 days. Eight days after infection,
the cells were stained for SAP25 and
PML.
|
![]() View larger version (34K): [in a new window] |
FIG. 9. ICAT
proteomic analysis of the SAP25 complex. HeLa cells were transfected
with FLAG-SAP25 or with FLAG-SAP25 and PML. The cell lysates were
immunoprecipitated with anti-FLAG antibody under nondenaturing
conditions. The two protein complexes were labeled with the ICAT
reagents (light ICAT for the FLAG-SAP25 sample and heavy ICAT for the
FLAG-SAP25-plus-PML sample). The two labeled protein complexes were
combined, proteolyzed to peptides with trypsin, and fractionated by
cation-exchange chromatography followed by avidin affinity
chromatography. The purified ICAT-labeled peptides were analyzed by
microcapillary liquid chromatography-tandem mass spectrometry
(µLC-MS/MS) for amino acid sequence determination and relative
quantification.
|
|
View this table: [in a new window] |
TABLE 1. Proteins
identified in the FLAG-SAP25 complex
|
|
|
|---|
We have cloned and characterized the 25-kDa mSin3A-associated polypeptide, SAP25. SAP25 is a novel protein that binds to the PAH1 domain of mSin3A. SAP25 associates with mSin3-HDAC complex in vivo and is capable of repressing transcription when tethered to DNA. SAP25 does not display any significant homology to known enzymes. It does not have any recognizable DNA-binding motifs and does not display significant in vitro DNA-binding activities (Y. Shiio, unpublished data). Thus, it seems possible that SAP25 is a docking protein, perhaps permitting association between mSin3 and other repression components such as PML (see below).
The interaction of SAP25 with mSin3A is mediated by a C-terminal region of SAP25 including an LXXLL motif, and mutation of this motif abolished the interaction. The LXXLL motifs in other proteins have been implicated in the binding to nuclear hormone receptors and cyclin D1, but the LXXLL motif of SAP25 does not mediate interaction with these proteins and is specific to the PAH1 domain of mSin3. Another PAH1-binding domain in the POZ domain of PLZF also contains an LDDLL sequence (10). These LXXLL motifs may be a new class of LXXLL motifs that mediate the binding to mSin3 PAH1, but not to nuclear hormone receptors or cyclin D1. The PAH1-binding domain of SAP25 does not display any significant homology to other PAH1-binding domains of N-CoR (2, 21), Pf1 (63), and HCF (57). The mSin3-binding domain of SAP25 displays an order-of-magnitude-higher affinity to mSin3 PAH1 than the PAH1-binding domain of N-CoR (I. Radhakrishnan, personal communication) and may represent a unique PAH1 interaction domain. Nuclear magnetic resonance structural analysis of the complex between the mSin3A PAH1 domain and the SAP25 PAH1 interaction domain is currently under way (I. Radhakrishnan, unpublished data).
SAP25 is actively exported from the nucleus by a CRM1-dependent mechanism. SAP25 has at least two nuclear export signals, one of which overlaps with the PAH1-binding LXXLL motif (Fig. 7C). Quite divergent leucine-rich sequences were shown to function as CRM1-dependent nuclear export signals (29, 31). Compilation of 58 functional leucine-rich NES sequences indicated that only 36% of them fit the previously proposed NES consensus, L-x(2,3)-[LIVFM]-x(2,3)-L-x-[LI] (31). In fact, an optimal CRM1-binding sequence, identified by using a random peptide library, inhibited the release of the nuclear export complex from the nuclear pore complex, suggesting that leucine-rich nuclear export signals have evolved to be low affinity and divergent (29). The LXXLL motif of SAP25 may represent another example of a divergent, low-affinity CRM1-binding nuclear export signal, although the binding of SAP25 and CRM1 was nonetheless detectable by immunoprecipitation-ICAT analysis (Table 1). Several lines of evidence suggest a role of PML in the nucleocytoplasmic shuttling of SAP25. Endogenous SAP25 in HeLa cells is mainly cytoplasmic, but a fraction of SAP25 is located in PML nuclear bodies (Fig. 8A). Furthermore, treatment with leptomycin B, an inhibitor of CRM1-dependent nuclear export, induced accumulation of SAP25 in PML nuclear bodies (Fig. 8A). Coexpression of PML induced a striking accumulation of SAP25 in PML nuclear bodies and the nucleoplasm (Fig. 8A). PML expression is induced upon Ras-induced senescence of primary fibroblasts, and the PML nuclear bodies increase in size and number during this process (14, 46). Concomitant with enhanced PML expression, SAP25 accumulates in PML nuclear bodies upon Ras-induced senescence (Fig. 8B). Several proteins located in PML nuclear bodies such as p53 (34), MDM2 (34), TRADD (40), and RBCK1 (53) are nucleocytoplasmic shuttling proteins and accumulate in PML nuclear bodies upon leptomycin B treatment. The precise role of PML in the shuttling of these proteins is not clear, but PML itself also has a CRM1-dependent nuclear export signal (22) and is exported to the cytoplasm upon human immunodeficiency virus infection (54). SAP25 is a new member of the growing family of nucleocytoplasmic shuttling proteins that are located in PML nuclear bodies.
PML nuclear bodies are implicated in diverse cellular functions such as gene regulation, apoptosis, senescence, DNA repair, and antiviral response (11). There is also evidence that RNA polymerase II and its nascent transcripts localize in PML nuclear bodies, suggesting that active transcription takes place in these structures (35, 55). PML was shown to interact with multiple corepressors (mSin3A, N-CoR, and c-Ski) and HDAC1, and this interaction was proposed to mediate the transcriptional repression by Mad (26). SAP25 may recruit the mSin3-HDAC complex to PML nuclear bodies and modulate gene transcription. The enhanced association of TFIIB with SAP25 upon PML coexpression (Table 1) may also hint at a role of SAP25 in regulation of basal transcription. However, the role of SAP25 may not be limited to gene transcription. Recently, human Sir2 deacetylase was shown to be recruited to PML nuclear bodies and antagonize PML-induced acetylation of p53 and PML-induced cellular senescence (36). Similarly, SAP25 may recruit the mSin3-HDAC complex to PML nuclear bodies and induce deacetylation of p53 or some other key regulator(s), modulating cellular senescence. The association of SAP25 with CDK4 and p16(INK4a) (Table 1) may also suggest a nontranscriptional role for SAP25. In conclusion, we have identified a novel mSin3-binding protein, SAP25. SAP25 is a new class of core components of mSin3 complex, which is constantly shuttling between the nucleus and the cytoplasm and whose subcellular location is regulated by PML. The precise biochemical and biological role of SAP25 remains to be established, but the present findings suggest that it plays a regulatory role in repression of transcription.
This work was supported by NIH grant R37CA057138 (R.N.E.); by federal funding from the National Heart, Blood, and Lung Institute under contract N01-HV-28179 (R.A.); by the NCI-Japanese Foundation for Cancer Research Training Program in the U.S.-Japan Cooperative Cancer Committee (Y.S.); by the Interdisciplinary Research Training Fellowship from the Fred Hutchinson Cancer Research Center (Y.S.); and by a gift from Merck and Co. to the ISB. R.N.E. is a Research Professor of the American Cancer Society.
|
|
|---|
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»